1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Chromosome 7, monosomy: new trials by email Literature Review of Chromosome 7, monosomy trials Research Report on Chromosome 7, monosomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies Fludarabine, Busulfan, Melphalan - Hematologic Malignancy, Acute Leukemia | Phase 2 | Recruiting | Masonic Cancer Center, University of Minnesota | 70 | 2023-05-11 | 2026-04-06 |
| A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies Withdrawal of immunosuppression and donor lymphocyte infusion - Acute Leukemia, Acute Myeloid Leukemia | Phase 2 | Completed | University of California, San Francisco | 43 | 2009-10-01 | 2016-06-23 |
Leukemia, Myeloid, Acute (2) · Leukemia, Myelomonocytic, Juvenile (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Anemia, Refractory, with Excess of Blasts (1) · Chromosome Aberrations (1) · Hematologic Neoplasms (1) · Influenza, Human (1) · Leukemia (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Myelodysplastic Syndromes (1) · Neoplasm, Residual (1) · Neoplasms (1) · Neurofibromatosis 1 (1) · beta-Thalassemia (1)
Bone Marrow Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia, Lymphoid (2) · Leukemia, Myeloid (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Myelodysplastic-Myeloproliferative Diseases (2) · Neoplasms by Histologic Type (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Anemia (1) · Anemia, Hemolytic (1)
Busulfan (1) · Cyclophosphamide (1) · Levetiracetam (1) · Melphalan (1) · Rituximab (1) · fludarabine (1) · thymoglobulin (1)
Masonic Cancer Center, University of Minnesota (1) · University of California, San Francisco (1)
United States (2)
Biljana Horn, M.D. (1) · Margaret MacMillan (1)